Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

• PAO W

収録刊行物

• PLoS Med

  PLoS Med 2 e73-, 2005

詳細情報

• CRID: 1572543024914897536
• NII論文ID: 10029048120
• データソース種別:
  • CiNii Articles